Accession Number: | 0001127602-23-012593 |
Date: | 2023-04-03 |
Issuer: | APELLIS PHARMACEUTICALS, INC. (APLS) |
Original Submission Date: |
TOWNSEND ADAM J.
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM, MA 02451
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2023-04-03 | M | 5,000 | a | $15.09 | 80,995 | direct | ||
COMMON STOCK | 2023-04-03 | S | 5,000 | d | $74.05 | 75,995 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 15.09 | 2023-04-03 | deemed execution date | M | 5,000 (d) | 2028-11-15 | common stock 5,000 | $15.09 | 287,500 | direct |
ID | footnote |
---|---|
f1 | this is a scheduled exercise and sale from an established 10b5-1 plan. |
f2 | this option was granted on november 16, 2018 and vests as to 25% of the shares underlying the options on the first anniversary of mr. townsend's date of hire, november 16, 2018, with the remaining 75% of the shares underlying the option vesting in equal monthly installments thereafter through the fourth anniversary of his date of hire, subject to continued service. |